Table of Contents Author Guidelines Submit a Manuscript
International Journal of Biomaterials
Volume 2018, Article ID 2952085, 29 pages
https://doi.org/10.1155/2018/2952085
Review Article

Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action

1Department of Chemistry, Western Region Campus, Institute of Engineering, Tribhuvan University, Pokhara, Nepal
2Central Department of Chemistry, Tribhuvan University, Kathmandu, Nepal

Correspondence should be addressed to Paras Nath Yadav; moc.liamg@912vadaynp

Received 28 July 2018; Revised 26 November 2018; Accepted 4 December 2018; Published 30 December 2018

Academic Editor: Alexander Seifalian

Copyright © 2018 Hari Sharan Adhikari and Paras Nath Yadav. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Ramya, P. N. Sudha, and J. Mahalakshmi, “Preparation and Characterization of Chitosan Binary Blend,” International Journal of Scientific and Research Publications, vol. 2, pp. 1–9, 2012. View at Google Scholar
  2. Y. Yuan, B. M. Chesnutt, W. O. Haggard, and J. D. Bumgardner, “Deacetylation of chitosan: Material characterization and in vitro evaluation via albumin adsorption and pre-osteoblastic cell cultures,” Materials , vol. 4, no. 8, pp. 1399–1416, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. T. Zhang, D. H. Chen, and L. Chen, “Preparation of two different serials of chitosan,” Journal of Dong Hua University (English Edition), vol. 19, pp. 36–39, 2002. View at Google Scholar
  4. Y. N. Gavhane, A. S. Gurav, and A. V. Yadav, “Chitosan and Its Applications: A Review of Literature,” International journal of research in pharmaceutical and biomedical sciences, vol. 4, no. 1, pp. 312–331, 2013. View at Google Scholar
  5. S. D. Ray, “Potential aspects of chitosan as pharmaceutical excipient,” Acta Poloniae Pharmaceutica, vol. 68, no. 5, pp. 619–622, 2011. View at Google Scholar
  6. A. M. M. Sadeghi, F. A. Dorkoosh, M. R. Avadi et al., “Permeation enhancer effect of chitosan and chitosan derivatives: Comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 70, no. 1, pp. 270–278, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Gu, W. Sun, H. Zhou et al., “The performance of a fly-larva shell-derived chitosan sponge as an absorbable surgical hemostatic agent,” Biomaterials, vol. 31, no. 6, pp. 1270–1277, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Burkatovskaya, G. P. Tegos, E. Swietlik, T. N. Demidova, A. P Castano, and M. R. Hamblin, “Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice,” Biomaterials, vol. 27, no. 22, pp. 4157–4164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. J. H. Park, G. Saravanakumar, K. Kim, and I. C. Kwon, “Targeted delivery of low molecular drugs using chitosan and its derivatives,” Advanced Drug Delivery Reviews, vol. 62, no. 1, pp. 28–41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. K. Park, M. J. Chung, H. N. Choi, and Y. I. Park, “Effects of the molecular weight and the degree of deacetylation of chitosan oligosaccharides on antitumor activity,” International Journal of Molecular Sciences, vol. 12, no. 1, pp. 266–277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Günbeyaz, A. Faraji, A. Özkul, N. Purali, and S. Şenel, “Chitosan based delivery systems for mucosal immunization against bovine herpesvirus 1 (BHV-1),” European Journal of Pharmaceutical Sciences, vol. 41, no. 3-4, pp. 531–545, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. S. Wimardhani, D. F. Suniarti, H. J. Freisleben, S. I. Wanadi, and M. A. Ikeda, “Cytotoxic effects of chitosan against oral cancer cell lines is molecular-weight-dependent and cell-type-specific,” International Journal of Oral Research, vol. 3, p. e1, 2012. View at Google Scholar
  13. Y. S. Wimardhani, D. F. Suniarti, H. J. Freisleben, S. I. Wanandi, N. C. Siregar, and M.-A. Ikeda, “Chitosan exerts anticancer activity through induction of apoptosis and cell cycle arrest in oral cancer cells,” Journal of oral science, vol. 56, no. 2, pp. 119–126, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Xia, P. Liu, and J. Liu, “Advance in chitosan hydrolysis by non-specific cellulases,” Bioresource Technology, vol. 99, no. 15, pp. 6751–6762, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. B. A. Vishu Kumar, M. C. Varadaraj, and R. N. Tharanathan, “Low molecular weight chitosan - Preparation with the aid of pepsin, characterization, and its bactericidal activity,” Biomacromolecules, vol. 8, no. 2, pp. 566–572, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Huang, E. Khor, and L.-Y. Lim, “Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation,” Pharmaceutical Research, vol. 21, no. 2, pp. 344–353, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Xu, Z. Wen, and Z. Xu, “Chitosan nanoparticles inhibit the growth of human hepatocellular carcinoma xenografts through an antiangiogenic mechanism,” Anticancer Research, vol. 29, no. 12, pp. 5103–5109, 2009. View at Google Scholar · View at Scopus
  18. K. V. Harish Prashanth and R. N. Tharanathan, “Depolymerized products of chitosan as potent inhibitors of tumor-induced angiogenesis,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1722, no. 1, pp. 22–29, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Maeda and Y. Kimura, “Antitumor Effects of Various Low-Molecular-Weight Chitosans Are Due to Increased Natural Killer Activity of Intestinal Intraepithelial Lymphocytes in Sarcoma 180-Bearing Mice,” Journal of Nutrition, vol. 134, no. 4, pp. 945–950, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Qin, Y. Du, L. Xiao, Z. Li, and X. Gao, “Enzymic preparation of water-soluble chitosan and their antitumor activity,” International Journal of Biological Macromolecules, vol. 31, no. 1–3, pp. 111–117, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. S.-L. Wang, H.-T. Lin, T.-W. Liang, Y.-J. Chen, Y.-H. Yen, and S.-P. Guo, “Reclamation of chitinous materials by bromelain for the preparation of antitumor and antifungal materials,” Bioresource Technology, vol. 99, no. 10, pp. 4386–4393, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Yamada, T. Ganno, N. Ohara, and Y. Hayashi, “Chitosan monomer accelerates alkaline phosphatase activity on human osteoblastic cells under hypofunctional conditions,” Journal of Biomedical Materials Research Part A, vol. 83, no. 2, pp. 290–295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Kumar, J. Dutta, and P. Dutta, “Preparation and characterization of N-heterocyclic chitosan derivative based gels for biomedical applications,” International Journal of Biological Macromolecules, vol. 45, no. 4, pp. 330–337, 2009. View at Publisher · View at Google Scholar
  24. S. Kumar, N. Nigam, T. Ghosh et al., “Preparation, characterization and optical properties of a novel azo-based chitosan biopolymer,” Materials Chemistry and Physics, vol. 120, no. 2-3, pp. 361–370, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Kumar, P. K. Dutta, and P. Sen, “Preparation and characterization of optical property of crosslinkable film of chitosan with 2-thiophenecarboxaldehyde,” Carbohydrate Polymers, vol. 80, no. 2, pp. 564–570, 2010. View at Google Scholar · View at Scopus
  26. S. Kumar, J. Koh, D. K. Tiwari, and P. K. Dutta, “Optical Study of Chitosan-Ofloxacin Complex for Biomedical Applications,” Journal of Macromolecular Science, Part A Pure and Applied Chemistry, vol. 48, no. 10, pp. 789–795, 2011. View at Publisher · View at Google Scholar
  27. N. M. Alves and J. F. Mano, “Chitosan derivatives obtained by chemical modifications for biomedical and environmental applications,” International Journal of Biological Macromolecules, vol. 43, no. 5, pp. 401–414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Jayakumar, K. P. Chennazhi, R. A. A. Muzzarelli, H. Tamura, S. V. Nair, and N. Selvamurugan, “Chitosan conjugated DNA nanoparticles in gene therapy,” Carbohydrate Polymers, vol. 79, no. 1, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Jayakumar, N. Nwe, S. Tokura, and H. Tamura, “Sulfated chitin and chitosan as novel biomaterials,” International Journal of Biological Macromolecules, vol. 40, no. 3, pp. 175–181, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Jayakumar, M. Prabaharan, S. V. Nair, and H. Tamura, “Novel chitin and chitosan nanofibers in biomedical applications,” Biotechnology Advances, vol. 28, no. 1, pp. 142–150, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. K. S. Batista, L. F. Pinto, C. A. R. Gomes, and P. Gomes, “Novel highly-soluble peptide-chitosan polymers: Chemical synthesis and spectral characterization,” Carbohydrate Polymers, vol. 64, no. 2, pp. 299–305, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. V. K. Mourya and N. N. Inamdar, “Chitosan-modifications and applications: opportunities galore,” Reactive and Functional Polymers, vol. 68, no. 6, pp. 1013–1051, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. U. Manna, S. Bharani, and S. Patil, “Layer-by-layer self-assembly of modified hyaluronic acid/chitosan based on hydrogen bonding,” Biomacromolecules, vol. 10, no. 9, pp. 2632–2639, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Jayakumar, M. Prabaharan, R. L. Reis, and J. F. Mano, “Graft copolymerized chitosan—present status and applications,” Carbohydrate Polymers, vol. 62, no. 2, pp. 142–158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Jayakumar, H. Nagahama, T. Furuike, and H. Tamura, “Synthesis of phosphorylated chitosan by novel method and its characterization,” International Journal of Biological Macromolecules, vol. 42, no. 4, pp. 335–339, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Jayakumar and H. Tamura, “Synthesis, characterization and thermal properties of chitin-g-poly(ɛ-caprolactone) copolymers by using chitin gel,” International Journal of Biological Macromolecules, vol. 43, no. 1, pp. 32–36, 2008. View at Publisher · View at Google Scholar
  37. R. Jayakumar, M. Prabaharan, P. T. Sudheesh Kumar, S. V. Nair, and H. Tamura, “Biomaterials based on chitin and chitosan in wound dressing applications,” Biotechnology Advances, vol. 29, no. 3, pp. 322–337, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. N. S. Rejinold, K. P. Chennazhi, S. V. Nair, H. Tamura, and R. Jayakumar, “Biodegradable and thermo-sensitive chitosan-g-poly(N-vinylcaprolactam) nanoparticles as a 5-fluorouracil carrier,” Carbohydrate Polymers, vol. 83, no. 2, pp. 776–786, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. Z. Zhong, Z. Zhong, R. Xing, P. Li, and G. Mo, “The preparation and antioxidant activity of 2-[phenylhydrazine (or hydrazine)-thiosemicarbazone]-chitosan,” International Journal of Biological Macromolecules, vol. 47, no. 2, pp. 93–97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. J. M. McCord, “The evolution of free radicals and oxidative stress,” American Journal of Medicine, vol. 108, no. 8, pp. 652–659, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. R. L. Rao, M. Bharani, and V. Pallavi, “Role of antioxidants and free radicals in health and disease,” Advances in Pharmacology And Toxicology, vol. 7, pp. 29–38, 2006. View at Google Scholar
  42. Y. Zheng, Y. Yi, Y. Qi, Y. Wang, W. Zhang, and M. Du, “Preparation of chitosan-copper complexes and their antitumor activity,” Bioorganic & Medicinal Chemistry Letters, vol. 16, no. 15, pp. 4127–4129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. R.-M. Wang, N.-P. He, P.-F. Song, Y.-F. He, L. Ding, and Z. Lei, “Preparation of low-molecular-weight chitosan derivative zinc complexes and their effect on the growth of liver cancer cells in vitro,” Pure and Applied Chemistry, vol. 81, no. 12, pp. 2397–2405, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. X. Yin, X. Zhang, Q. Lin, Y. Feng, W. Yu, and Q. Zhang, “Metal-coordinating controlled oxidative degradation of chitosan and antioxidant activity of chitosan-metal complex,” Arkivoc, vol. 2004, no. 9, pp. 66–78, 2004. View at Google Scholar · View at Scopus
  45. Z. Jiang, B. Han, H. Li, Y. Yang, and W. Liu, “Carboxymethyl chitosan represses tumor angiogenesis in vitro and in vivo,” Carbohydrate Polymers, vol. 129, pp. 1–8, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Kumar, J. Koh, H. Kim, M. K. Gupta, and P. K. Dutta, “A new chitosan-thymine conjugate: Synthesis, characterization and biological activity,” International Journal of Biological Macromolecules, vol. 50, no. 3, pp. 493–502, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Jiang, H. Ouyang, P. Ruan et al., “Chitosan derivatives inhibit cell proliferation and induce apoptosis in breast cancer cells,” Anticancer Research, vol. 31, no. 4, pp. 1321–1328, 2011. View at Google Scholar · View at Scopus
  48. Y. Kato, H. Onishi, and Y. Machida, “Contribution of chitosan and its derivatives to cancer chemotherapy,” In Vivo, vol. 19, no. 1, pp. 301–310, 2005. View at Google Scholar · View at Scopus
  49. E. V. Svirshchevskaya, I. A. Gracheva, A. G. Kuznetsov, and E. V. Myrsikova, “Antitumor Activity of Furanoallocolchicinoid-Chitosan Conjugate,” Medicinal Chemistry, vol. 6, no. 9, pp. 571–577, 2016. View at Publisher · View at Google Scholar
  50. N. Salahuddin, A. A. Elbarbary, and H. A. Alkabes, “Quinazolinone derivatives loaded polypyrrole/chitosan core-shell nanoparticles with different morphologies: Antibacterial and anticancer activities,” Nano, vol. 12, no. 1, Article ID 1750002, 17 pages, 2017. View at Google Scholar · View at Scopus
  51. N. Salahuddin, A. A. Elbarbary, and H. A. Alkabes, “Antibacterial and antitumor activities of 3-amino-phenyl-4(3H)-quinazolinone/polypyrrole chitosan core shell nanoparticles,” Polymer Bulletin, vol. 74, no. 5, pp. 1775–1790, 2017. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Pestov and S. Bratskaya, “Chitosan and its derivatives as highly efficient polymer ligands,” Molecules, vol. 21, no. 3, article no. 330, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Q. Qin, Y. M. Du, and L. Xiao, “Effect of hydrogen peroxide treatment on the molecular weight and structure of chitosan,” Polymer Degradation and Stability, vol. 76, no. 2, pp. 211–218, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. N. A. Mohamed, R. R. Mohamed, and R. S. Seoudi, “Synthesis and characterization of some novel antimicrobial thiosemicarbazone O-carboxymethyl chitosan derivatives,” International Journal of Biological Macromolecules, vol. 63, pp. 163–169, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. X.-G. Chen and H.-J. Park, “Chemical characteristics of O-carboxymethyl chitosans related to the preparation conditions,” Carbohydrate Polymers, vol. 53, no. 4, pp. 355–359, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Fangkangwanwong, N. Sae-Liang, C. Sriworarat, A. Sereemaspun, and S. Chirachanchai, “Water-Based Chitosan for Thymine Conjugation: A Simple, Efficient, Effective, and Green Pathway to Introduce Cell Compatible Nucleic Acid Recognition,” Bioconjugate Chemistry, vol. 27, no. 10, pp. 2301–2306, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. X.-J. Liu and R.-Y. Chen, “Synthesis of novel phosphonotripeptides containing uracil or thymine group,” Phosphorus, Sulfur, and Silicon and the Related Elements, vol. 176, pp. 19–28, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Kuan-Han, B.-R. Huang, and C.-C. Tzeng, “Synthesis and anticancer evaluation of certain α-methylene-γ-(4- substituted phenyl)-γ-butyrolactone bearing thymine, uracil, and 5- bromouracil,” Bioorganic & Medicinal Chemistry Letters, vol. 9, no. 2, pp. 241–244, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Skiba, R. Karpowicz, I. Szabó, B. Therrien, and K. Kowalski, “Synthesis and anticancer activity studies of ferrocenyl-thymine-3,6-dihydro-2H-thiopyranes - A new class of metallocene-nucleobase derivatives,” Journal of Organometallic Chemistry, vol. 794, pp. 216–222, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. A. K. Singla and M. Chawla, “Chitosan: some pharmaceutical and biological aspects—an update,” Journal of Pharmacy and Pharmacology, vol. 53, no. 8, pp. 1047–1067, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. C. K. S. Pillai, W. Paul, and C. P. Sharma, “Chitin and chitosan polymers: chemistry, solubility and fiber formation,” Progress in Polymer Science, vol. 34, no. 7, pp. 641–678, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Y. Lee, W. S. Ha, and W. H. Park, “Blood compatibility and biodegradability of partially N-acylated chitosan derivatives,” Biomaterials, vol. 16, no. 16, pp. 1211–1216, 1995. View at Publisher · View at Google Scholar · View at Scopus
  63. B. Carreño-Gómez and R. Duncan, “Evaluation of the biological properties of soluble chitosan and chitosan microspheres,” International Journal of Pharmaceutics, vol. 148, no. 2, pp. 231–240, 1997. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. Song, H. Onishi, and T. Nagai, “Synthesis and Drug-Release Characteristics of the Conjugates of Mitomycin C with N-Succinyl-chitosan and Carboxymethyl-chitin,” Chemical & Pharmaceutical Bulletin, vol. 40, no. 10, pp. 2822–2825, 1992. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. Song, H. Onishi, and T. Nagai, “Conjugate of mitomycin C with N-succinyl-chitosan: In vitro drug release properties, toxicity and antitumor activity,” International Journal of Pharmaceutics, vol. 98, no. 1-3, pp. 121–130, 1993. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Song, H. Onishi, and T. Nagai, “Toxicity and antitumor activity of the conjugate of mitomycin C with carboxymethyl-chitin,” Yakuzaigaku, vol. 53, pp. 141–147, 1993. View at Google Scholar
  67. K. Kamiyama, H. Onishi, and Y. Machida, “Biodisposition characteristics of N-succinyl-chitosan and glycol- chitosan in normal and tumor-bearing mice,” Biological & Pharmaceutical Bulletin, vol. 22, no. 2, pp. 179–186, 1999. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Kato, H. Onishi, and Y. Machida, “Evaluation of N-succinyl-chitosan as a systemic long-circulating polymer,” Biomaterials, vol. 21, no. 15, pp. 1579–1585, 2000. View at Publisher · View at Google Scholar · View at Scopus
  69. J. Hosoda, S. Unezaki, K. Maruyama, S. Tsuchiya, and M. Iwatsuru, “Antitumor activity of doxorubicin encapsulated in poly(ethylene glycol)-coated liposomes,” Biological & Pharmaceutical Bulletin, vol. 18, no. 9, pp. 1234–1237, 1995. View at Publisher · View at Google Scholar · View at Scopus
  70. T. Nakanishi, S. Fukushima, K. Okamoto et al., “Development of the polymer micelle carrier system for doxorubicin,” Journal of Controlled Release, vol. 74, no. 1-3, pp. 295–302, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Yan, D. Chen, J. Gu, H. Hu, X. Zhao, and M. Qiao, “Preparation of N-succinyl-chitosan and their physical-chemical properties as a novel excipient,” Yakugaku Zasshi, vol. 126, no. 9, pp. 789–793, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Song, H. Onishi, and T. Nagai, “Pharmacokinetic characteristics and antitumor activity of the n-succinyl-chitosan-mitomycin C conjugate and the carboxymethyl-chitin-mitomycin C conjugate,” Biological & Pharmaceutical Bulletin, vol. 16, no. 1, pp. 48–54, 1993. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Muslim, M. Morimoto, H. Saimoto, Y. Okamoto, S. Minami, and Y. Shigemasa, “Synthesis and bioactivities of poly(ethylene glycol)-chitosan hybrids,” Carbohydrate Polymers, vol. 46, no. 4, pp. 323–330, 2001. View at Publisher · View at Google Scholar · View at Scopus
  74. B. J. Crielaard, S. van der Wal, T. Lammers et al., “A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy.,” International Journal of Nanomedicine, vol. 6, pp. 2697–2703, 2011. View at Google Scholar · View at Scopus
  75. Y. V. Voitovich, E. S. Shegravina, N. S. Sitnikov et al., “Synthesis and biological evaluation of furanoallocolchicinoids,” Journal of Medicinal Chemistry, vol. 58, no. 2, pp. 692–704, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. R. Mathiyalagan, S. Subramaniyam, Y. J. Kim, Y.-C. Kim, and D. C. Yang, “Ginsenoside compound K-bearing glycol chitosan conjugates: Synthesis, physicochemical characterization, and in vitro biological studies,” Carbohydrate Polymers, vol. 112, pp. 359–366, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Thanou, J. C. Verhoef, and H. E. Junginger, “Chitosan and its derivatives as intestinal absorption enhancers,” Advanced Drug Delivery Reviews, vol. 50, no. 1, pp. S91–S101, 2001. View at Publisher · View at Google Scholar · View at Scopus
  78. K.-S. Nam and Y.-H. Shon, “Suppression of metastasis of human breast cancer cells by chitosan oligosaccharides,” Journal of Microbiology and Biotechnology, vol. 19, no. 6, pp. 629–633, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. H. Zhang, F. Wu, Y. Li et al., “Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone,” Beilstein Journal of Nanotechnology, vol. 7, pp. 1861–1870, 2016. View at Publisher · View at Google Scholar
  80. S. Kuppusamy and J. Karuppaiah, “Screening of Antiproliferative Effect of Chitosan on Tumor Growth and Metastasis in T24 Urinary Bladder Cancer Cell Line,” Austrl-Asian Journal of Cancer, vol. 12, no. 3, pp. 145–149, 2013. View at Google Scholar
  81. H. Hosseinzadeh, F. Atyabi, R. Dinarvand, and S. N. Ostad, “Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study,” International Journal of Nanomedicine, vol. 7, pp. 1851–1863, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. K.-T. Shen, M.-H. Chen, H.-Y. Chan, J.-H. Jeng, and Y.-J. Wang, “Inhibitory effects of chitooligosaccharides on tumor growth and metastasis,” Food and Chemical Toxicology, vol. 47, no. 8, pp. 1864–1871, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. C. Qin, B. Zhou, L. Zeng et al., “The physicochemical properties and antitumor activity of cellulase-treated chitosan,” Food Chemistry, vol. 84, no. 1, pp. 107–115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. A. Tokoro, K. Suzuki, T. Matsumoto, T. Mikami, S. Suzuki, and M. Suzuki, “Chemotactic Response of Human Neutrophils to N-Acetyl Chitohexaose in vitro,” Microbiology and Immunology, vol. 32, no. 4, pp. 387–395, 1988. View at Publisher · View at Google Scholar · View at Scopus
  85. W.-G. Seo, H.-O. Pae, N.-Y. Kim et al., “Synergistic cooperation between water-soluble chitosan oligomers and interferon-γ for induction of nitric oxide synthesis and tumoricidal activity in murine peritoneal macrophages,” Cancer Letters, vol. 159, no. 2, pp. 189–195, 2000. View at Publisher · View at Google Scholar · View at Scopus
  86. K. Suzuki, T. Mikami, Y. Okawa, A. Tokoro, S. Suzuki, and M. Suzuki, “Antitumor effect of hexa-N-acetylchitohexaose and chitohexaose,” Carbohydrate Research, vol. 151, pp. 403–408, 1986. View at Publisher · View at Google Scholar · View at Scopus
  87. K. Tsukada, T. Matsumoto, K. Aizawa et al., “Antimetastatic and Growth‐inhibitory Effects of N‐Acetylchitohexaose in Mice Bearing Lewis Lung Carcinoma,” Japanese Journal of Cancer Research, vol. 81, no. 3, pp. 259–265, 1990. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Tokoro, M. Kobayashi, N. Tatewaki et al., “Protective Effect of N-Acetyl Chitohexaose on Listeria monocytogenes Infection in Mice,” Microbiology and Immunology, vol. 33, no. 4, pp. 357–367, 1989. View at Publisher · View at Google Scholar · View at Scopus
  89. F. Y. Wang and Y. S. He, “Study on antitumor effect of water-soluble chitosan,” Journal of Clinical Biochemistry Drug, vol. 22, pp. 21-22, 2001. View at Google Scholar
  90. J. C. Fernandes, J. Sereno, P. Garrido et al., “Inhibition of bladder tumor growth by chitooligosaccharides in an experimental carcinogenesis model,” Marine Drugs, vol. 10, no. 12, pp. 2661–2675, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Sugano, T. Fujikawa, Y. Hiratsuji, K. Nakashima, N. Fukuda, and Y. Hasegawa, “A novel use of chitosan as a hypocholesterolemic agent in rats,” American Journal of Clinical Nutrition, vol. 33, no. 4, pp. 787–793, 1980. View at Publisher · View at Google Scholar · View at Scopus
  92. H. Takimoto, M. Hasegawa, K. Yagi, T. Nakamura, T. Sakaeda, and M. Hirai, “Proapoptotic effect of a dietary supplement: water soluble chitosan activates caspase-8 and modulating death receptor expression.,” Drug Metabolism and Pharmacokinetics, vol. 19, no. 1, pp. 76–82, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. J. Zhang, W. Xia, P. Liu et al., “Chitosan modification and pharmaceutical/biomedical applications,” Marine Drugs, vol. 8, no. 7, pp. 1962–1987, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Hasegawa, K. Yagi, S. Iwakawa, and M. Hirai, “Chitosan induces apoptosis via caspase-3 activation in bladder tumor cells,” Japanese Journal of Cancer Research, vol. 92, no. 4, pp. 459–466, 2001. View at Publisher · View at Google Scholar · View at Scopus
  95. L. Qi, Z. Xu, and M. Chen, “In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles,” European Journal of Cancer, vol. 43, no. 1, pp. 184–193, 2007. View at Publisher · View at Google Scholar · View at Scopus
  96. J.-W. Ai, W. Liao, and Z.-L. Ren, “Enhanced anticancer effect of copper-loaded chitosan nanoparticles against osteosarcoma,” RSC Advances, vol. 7, no. 26, pp. 15971–15977, 2017. View at Publisher · View at Google Scholar · View at Scopus
  97. T. Ramasamy, H. B. Ruttala, N. Chitrapriya et al., “Engineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumors,” Acta Biomaterialia, vol. 48, pp. 131–143, 2017. View at Publisher · View at Google Scholar · View at Scopus
  98. K. Vermeulen, D. R. van Bockstaele, and Z. N. Berneman, “The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer,” Cell Proliferation, vol. 36, no. 3, pp. 131–149, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Senturk, M. Mumcuoglu, O. Gursoy-Yuzugullu, B. Cingoz, K. C. Akcali, and M. Ozturk, “Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth,” Hepatology, vol. 52, no. 3, pp. 966–974, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. J. Bartek and J. Lukas, “Mammalian G1- and S-phase checkpoints in response to DNA damage,” Current Opinion in Cell Biology, vol. 13, no. 6, pp. 738–747, 2001. View at Publisher · View at Google Scholar · View at Scopus
  101. G. J. Hannon and D. Beach, “p15INK4B is a potential effector of TGF-β-induced cell cycle arrest,” Nature, vol. 371, no. 6494, pp. 257–261, 1994. View at Publisher · View at Google Scholar · View at Scopus
  102. I. Reynisdottir, K. Polyak, A. Iavarone, and J. Massague, “Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β,” Genes & Development, vol. 9, no. 15, pp. 1831–1845, 1995. View at Publisher · View at Google Scholar · View at Scopus
  103. J. Falck, N. Mailand, R. G. Syljuåsen, J. Bartek, and J. Lukas, “The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis,” Nature, vol. 410, no. 6830, pp. 842–847, 2001. View at Publisher · View at Google Scholar · View at Scopus
  104. M. Saruc, S. Standop, J. Standop et al., “Pancreatic Enzyme Extract Improves Survival in Murine Pancreatic Cancer,” Pancreas, vol. 28, no. 4, pp. 401–412, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. K.-S. Nam, M.-K. Kim, and Y.-H. Shon, “Chemopreventive effect of chitosan oligosaccharide against colon carcinogenesis,” Journal of Microbiology and Biotechnology, vol. 17, no. 9, pp. 1546–1549, 2007. View at Google Scholar · View at Scopus
  106. K. S. Nam, M. K. Kim, and Y.-H. Shon, “Inhibition of proinflammatory cytokine-induced invasiveness of HT-29 cells by chitosan oligosaccharide,” Journal of Microbiology and Biotechnology, vol. 17, no. 12, pp. 2042–2045, 2007. View at Google Scholar
  107. H. Quan, F. Zhu, X. Han, Z. Xu, Y. Zhao, and Z. Miao, “Mechanism of anti-angiogenic activities of chitooligosaccharides may be through inhibiting heparanase activity,” Medical Hypotheses, vol. 73, no. 2, pp. 205-206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. H. Nagaset and J. F. Woessner Jr., “Matrix metalloproteinases,” The Journal of Biological Chemistry, vol. 274, no. 31, pp. 21491–21494, 1999. View at Publisher · View at Google Scholar · View at Scopus
  109. P. D. Brown, “Matrix metalloproteinases in gastrointestinal cancer,” Gut, vol. 43, no. 2, pp. 161–163, 1998. View at Publisher · View at Google Scholar · View at Scopus
  110. J. A. Lagares-Garcia, R. A. Moore, B. Collier, M. Heggere, F. Diaz, and F. Qian, “Nitric oxide synthase as a marker in colorectal carcinoma,” The American Surgeon, vol. 67, no. 7, pp. 709–713, 2001. View at Google Scholar · View at Scopus
  111. N. Yagihashi, H. Kasajima, S. Sugai et al., “Increased in situ expression of nitric oxide synthase in human colorectal cancer,” Virchows Archiv, vol. 436, no. 2, pp. 109–114, 2000. View at Publisher · View at Google Scholar · View at Scopus
  112. J. Folkman, “Angiogenesis and angiogenesis inhibition: an overview.,” EXS, vol. 79, pp. 1–8, 1997. View at Google Scholar · View at Scopus
  113. H.-T. Liu, P. Huang, P. Ma, Q.-S. Liu, C. Yu, and Y.-G. Du, “Chitosan oligosaccharides suppress LPS-induced IL-8 expression in human umbilical vein endothelial cells through blockade of p38 and Akt protein kinases,” Acta Pharmacologica Sinica, vol. 32, no. 4, pp. 478–486, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. Z. Hossain and K. Takahashi, “Induction of permeability and apoptosis in colon cancer cell line with chitosan,” Journal of Food and Drug Analysis, vol. 16, no. 5, pp. 1–8, 2008. View at Google Scholar · View at Scopus
  115. J. Dou, P. Ma, C. Xiong, C. Tan, and Y. Du, “Induction of apoptosis in human acute leukemia HL-60 cells by oligochitosan through extrinsic and intrinsic pathway,” Carbohydrate Polymers, vol. 86, no. 1, pp. 19–24, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. S.-M. Hwang, C.-Y. Chen, S.-S. Chen, and J.-C. Chen, “Chitinous materials inhibit nitric oxide production by activated RAW 264.7 macrophages,” Biochemical and Biophysical Research Communications, vol. 271, no. 1, pp. 229–233, 2000. View at Publisher · View at Google Scholar · View at Scopus
  117. M. Silano, O. Vincentini, R. A. A. Muzzarelli, C. Muzzarelli, and M. De Vincenzi, “MP-chitosan protects Caco-2 cells from toxic gliadin peptides,” Carbohydrate Polymers, vol. 58, no. 2, pp. 215–219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  118. K. M. Yamada and K. Clark, “Cell biology: Survival in three dimensions,” Nature, vol. 419, no. 6909, pp. 790-791, 2002. View at Publisher · View at Google Scholar · View at Scopus
  119. R. Wallace, J. Richard Thomson, M. J. Bell, and H. E. Skipper, “Observations on the Antileukemic Activity of Pyridine- 2-carboxaldehyde Thiosemicarbazone and Thiocarbohydrazone,” Cancer Research, vol. 16, no. 2, pp. 167–170, 1956. View at Google Scholar · View at Scopus
  120. F. A. French and E. J. Blanz Jr., “The Carcinostatic Activity of Thiosemicarbazones of Formyl Heteroaromatic Compounds,” Journal of Medicinal Chemistry, vol. 9, no. 4, pp. 585–589, 1966. View at Publisher · View at Google Scholar
  121. K. C. Agrawal and A. C. Sartorelli, “Potential Antitumor Agents. II. Effects of Modifications in the Side Chain of 1-Formylisoquinoline Thiosemicarbazone,” Journal of Medicinal Chemistry, vol. 12, no. 5, pp. 771–774, 1969. View at Publisher · View at Google Scholar · View at Scopus
  122. F. A. French and E. J. Blanz Jr., “Chemotherapy studies on experimental mouse tumors X,” Cancer Chemotherapy Reports Part 2, vol. 2, pp. 199–235, 1971. View at Google Scholar
  123. D. L. Klayman, J. F. Bartosevich, T. S. Griffin, C. J. Mason, and J. P. Scovill, “2-Acetylpyridine Thiosemicarbazones. 1. A New Class of Potential Antimalarial Agents,” Journal of Medicinal Chemistry, vol. 22, no. 7, pp. 855–862, 1979. View at Publisher · View at Google Scholar · View at Scopus
  124. L. Thelander and P. Reichard, “Reduction of ribonucleotides.,” Annual Review of Biochemistry, vol. 48, pp. 133–158, 1979. View at Publisher · View at Google Scholar · View at Scopus
  125. J. G. Cory and A. Sato, “Regulation of ribonucleotide reductase activity in mammalian cells,” Molecular and Cellular Biochemistry, vol. 53-54, no. 1-2, pp. 257–266, 1983. View at Publisher · View at Google Scholar · View at Scopus
  126. E. C. Moore and A. C. Sartorelli, “The inhibition of ribonucleotide reductase by alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones,” in Inhibitors of Ribonucleotide Diphosphate Reductase Activity, J. G. Cory and A. H. Cory, Eds., pp. 203–215, Pergamon Press, New York, NY, USA, 1989. View at Google Scholar
  127. W. Xie, P. Xu, and Q. Liu, “Antioxidant activity of water–soluble chitosan derivatives,” Bioorganic & Medicinal Chemistry Letters, vol. 11, no. 13, pp. 1699–1701, 2001. View at Publisher · View at Google Scholar · View at Scopus
  128. L. Astolfi, S. Ghiselli, V. Guaran et al., “Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation,” Oncology Reports, vol. 29, no. 4, pp. 1285–1292, 2013. View at Publisher · View at Google Scholar · View at Scopus
  129. M. A. Fuertes, C. Alonso, and J. M. Pérez, “Biochemical modulation of cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance,” Chemical Reviews, vol. 103, no. 3, pp. 645–662, 2003. View at Publisher · View at Google Scholar · View at Scopus
  130. H.-T. Arkenau, C. P. Carden, and J. S. de Bono, “Targeted agents in cancer therapy,” Medicine, vol. 36, no. 1, pp. 33–37, 2008. View at Publisher · View at Google Scholar · View at Scopus
  131. F. Arnesano and G. Natile, ““Platinum on the road”: Interactions of antitumoral cisplatin with proteins,” Pure and Applied Chemistry, vol. 80, no. 12, pp. 2715–2725, 2008. View at Publisher · View at Google Scholar · View at Scopus
  132. M. J. Hannon, “Metal-based anticancer drugs: From a past anchored in platinum chemistry to a post-genomic future of diverse chemistry and biology,” Pure and Applied Chemistry, vol. 79, no. 12, pp. 2243–2261, 2007. View at Publisher · View at Google Scholar · View at Scopus
  133. D. Steinborn and H. Junicke, “Carbohydrate complexes of platinum-group metals,” Chemical Reviews, vol. 100, no. 12, pp. 4283–4317, 2000. View at Publisher · View at Google Scholar · View at Scopus
  134. U. Kalinowska-Lis, J. Ochocki, and K. Matlawska-Wasowska, “Trans geometry in platinum antitumor complexes,” Coordination Chemistry Reviews, vol. 252, no. 12-14, pp. 1328–1345, 2008. View at Publisher · View at Google Scholar · View at Scopus
  135. A. J. Varma, S. V. Deshpande, and J. F. Kennedy, “Metal complexation by chitosan and its derivatives: a review,” Carbohydrate Polymers, vol. 55, no. 1, pp. 77–93, 2004. View at Publisher · View at Google Scholar · View at Scopus
  136. L. Gritsch, C. Lovell, W. H. Goldmann, and A. R. Boccaccini, “Fabrication and characterization of copper(II)-chitosan complexes as antibiotic-free antibacterial biomaterial,” Carbohydrate Polymers, vol. 179, pp. 370–378, 2018. View at Publisher · View at Google Scholar · View at Scopus
  137. L. Qi, Z. Xu, X. Jiang, C. Hu, and X. Zou, “Preparation and antibacterial activity of chitosan nanoparticles,” Carbohydrate Research, vol. 339, no. 16, pp. 2693–2700, 2004. View at Publisher · View at Google Scholar · View at Scopus
  138. P. Nurse, “A long twentieth century of the cell cycle and beyond,” Cell, vol. 100, no. 1, pp. 71–78, 2000. View at Publisher · View at Google Scholar · View at Scopus
  139. J. H. Niazi and M. B. Gu, “Toxicity of metallic nanoparticles in microorganisms- A review,” Atmospheric and Biological Environmental Monitoring, pp. 193–206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  140. O. Bondarenko, K. Juganson, A. Ivask, K. Kasemets, M. Mortimer, and A. Kahru, “Toxicity of Ag, CuO and ZnO nanoparticles to selected environmentally relevant test organisms and mammalian cells in vitro: a critical review,” Archives of Toxicology, vol. 87, no. 7, pp. 1181–1200, 2013. View at Publisher · View at Google Scholar · View at Scopus
  141. M. P. Murphy, “How mitochondria produce reactive oxygen species,” Biochemical Journal, vol. 417, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  142. M. Kurniasih, P. Purwati, D. Hermawan, and M. Zaki, “Optimum conditions for the synthesis of high solubility carboxymethyl chitosan,” Malaysian Journal of Fundamental and Applied Sciences, vol. 10, no. 4, pp. 189–194, 2014. View at Publisher · View at Google Scholar
  143. J. Ji, D. Wu, L. Liu, J. Chen, and Y. Xu, “Preparation, evaluation, and in vitro release of folic acid conjugated O-carboxymethyl chitosan nanoparticles loaded with methotrexate,” Journal of Applied Polymer Science, vol. 125, no. S2, pp. E208–E215, 2012. View at Publisher · View at Google Scholar · View at Scopus
  144. A. Anitha, K. P. Chennazhi, S. V. Nair, and R. Jayakumar, “5-Flourouracil loaded N,O-carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast cancer,” Journal of Biomedical Nanotechnology, vol. 8, no. 1, pp. 29–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  145. A. Anitha, S. Maya, N. Deepa, K. P. Chennazhi, S. V. Nair, and R. Jayakumar, “Curcumin-loaded N, O-carboxymethyl chitosan nanoparticles for cancer drug delivery,” Journal of Biomaterials Science, Polymer Edition, vol. 23, no. 11, pp. 1381–1400, 2012. View at Publisher · View at Google Scholar · View at Scopus
  146. Y. H. Jin, H. Hu, M. Qiao et al., “pH-sensitive chitosan-derived nanoparticles as doxorubicin carriers for effective anti-tumor activity: preparation and in vitro evaluation,” Colloids and Surfaces B: Biointerfaces, vol. 94, pp. 184–191, 2012. View at Publisher · View at Google Scholar
  147. Y. Wang, X. Yang, J. Yang et al., “Self-assembled nanoparticles of methotrexate conjugated O-carboxymethyl chitosan: Preparation, characterization and drug release behavior in vitro,” Carbohydrate Polymers, vol. 86, no. 4, pp. 1665–1670, 2011. View at Publisher · View at Google Scholar · View at Scopus
  148. M. Zheng, B. Han, Y. Yang, and W. Liu, “Synthesis, characterization and biological safety of O-carboxymethyl chitosan used to treat Sarcoma 180 tumor,” Carbohydrate Polymers, vol. 86, no. 1, pp. 231–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  149. J. Folkman, “New perspectives in clinical oncology from angiogenesis research,” European Journal of Cancer Part A: General Topics, vol. 32, no. 14, pp. 2534–2539, 1996. View at Publisher · View at Google Scholar · View at Scopus
  150. R. B. Effros, “Genetic alterations in the ageing immune system: Impact on infection and cancer,” Mechanisms of Ageing and Development, vol. 124, no. 1, pp. 71–77, 2003. View at Publisher · View at Google Scholar · View at Scopus
  151. W. Aulitzky, G. Gastl, W. E. Aulitzky et al., “Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma,” Journal of Clinical Oncology, vol. 7, no. 12, pp. 1875–1884, 1989. View at Publisher · View at Google Scholar · View at Scopus
  152. A. M. Eggermont, H. Schraffordt Koops, D. Liénard et al., “Isolated limb perfusion with high-dose tumor necrosis factor-α in combination with interferon-γ and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial,” Journal of Clinical Oncology, vol. 14, no. 10, pp. 2653–2665, 1996. View at Publisher · View at Google Scholar · View at Scopus
  153. L. M. Ebert, S. Meuter, and B. Moser, “Homing and function of human skin γδ T cells and NK cells: Relevance for tumor surveillance,” The Journal of Immunology, vol. 176, no. 7, pp. 4331–4336, 2006. View at Publisher · View at Google Scholar · View at Scopus
  154. L. Chang, H. Kamata, G. Solinas et al., “The E3 ubiquitin ligase itch couples JNK activation to TNFα-induced cell death by inducing c-FLIPL turnover,” Cell, vol. 124, no. 3, pp. 601–613, 2006. View at Publisher · View at Google Scholar · View at Scopus
  155. G. M. Hur, J. Lewis, Q. Yang et al., “The death domain kinase RIP has an essential role in DNA damage-induced NF-κB activation,” Genes & Development, vol. 17, no. 7, pp. 873–882, 2003. View at Publisher · View at Google Scholar · View at Scopus
  156. O. Trubiani, D. Bosco, and R. Di Primio, “Interferon-γ (IFN-γ) induces programmed cell death in differentiated human leukemia B cell lines,” Experimental Cell Research, vol. 215, no. 1, pp. 23–27, 1994. View at Publisher · View at Google Scholar · View at Scopus
  157. E. Ahn, G. Pan, S. M. Vickers, and J. M. McDonald, “IFN-gamma upregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma,” International Journal of Cancer, vol. 100, no. 4, pp. 445–451, 2002. View at Publisher · View at Google Scholar
  158. L.-M. Tumir, M. Grabar, S. Tomić, and I. Piantanida, “The interactions of bis-phenanthridinium-nucleobase conjugates with nucleotides: adenine-conjugate recognizes UMP in aqueous medium,” Tetrahedron, vol. 66, no. 13, pp. 2501–2513, 2010. View at Publisher · View at Google Scholar · View at Scopus
  159. A. R. Pike, L. C. Ryder, B. R. Horrocks et al., “Metallocene - DNA: Synthesis, molecular and electronic structure and DNA incorporation of C5-ferrocenylthymidine derivatives,” Chemistry - A European Journal, vol. 8, no. 13, pp. 2891–2899, 2002. View at Publisher · View at Google Scholar · View at Scopus
  160. S. Boncel, M. Mączka, K. K. Koziol, R. Motyka, and K. Z. Walczak, “Symmetrical and unsymmetrical α,ω-nucleobase amide-conjugated systems,” Beilstein Journal of Organic Chemistry, vol. 6, no. 34, 2010. View at Publisher · View at Google Scholar
  161. T. Ihara, A. Uemura, A. Futamura et al., “Cooperative DNA probing using a β-cyclodextrin DNA conjugate and a nucleobase-specific fluorescent ligand,” Journal of the American Chemical Society, vol. 131, no. 4, pp. 1386-1387, 2009. View at Publisher · View at Google Scholar · View at Scopus
  162. H. Kraatz, “Ferrocene-Conjugates of Amino Acids, Peptides and Nucleic Acids,” Journal of Inorganic and Organometallic Polymers and Materials, vol. 15, no. 1, pp. 83–106, 2005. View at Publisher · View at Google Scholar
  163. W. A. Wlassoff and G. C. King, “Ferrocene conjugates of dUTP for enzymatic redox labelling of DNA,” Nucleic Acids Research, vol. 30, no. 12, Article ID e58, 2002. View at Publisher · View at Google Scholar · View at Scopus
  164. Y. Xu, H. Jin, Z. Yang, L. Zhang, and L. Zhang, “Synthesis and biological evaluation of novel neamine-nucleoside conjugates potentially targeting to RNAs,” Tetrahedron, vol. 65, no. 27, pp. 5228–5239, 2009. View at Publisher · View at Google Scholar · View at Scopus
  165. T. Kubo, R. Bakalova, H. Ohba, and M. Fujii, “Antisense effects of DNA– peptide conjugates,” Nucleic Acids Research, no. 3, pp. 179-180, 2003. View at Google Scholar
  166. G. N. Roviello, E. Benedetti, C. Pedone, and E. M. Bucci, “Nucleobase-containing peptides: An overview of their characteristic features and applications,” Amino Acids, vol. 39, no. 1, pp. 45–57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  167. D. L. Nelson and M. M. Cox, “DNA Replication, in: Lehninger Principles of Biochemistry,” in Lehninger Principles of Biochemistry, pp. 950–966, 4th edition, 2005. View at Google Scholar
  168. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  169. D. G. Fernig and J. T. Gallagher, “Fibroblast growth factors and their receptors: An information network controlling tissue growth, morphogenesis and repair,” Progress in Growth Factor Research, vol. 5, no. 4, pp. 353–377, 1994. View at Publisher · View at Google Scholar · View at Scopus
  170. D. Qiao, K. Meyer, C. Mundhenke, S. A. Drew, and A. Friedl, “Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 signaling in brain endothelial cells: Specific role for glypican-1 in glioma angiogenesis,” The Journal of Biological Chemistry, vol. 278, no. 18, pp. 16045–16053, 2003. View at Publisher · View at Google Scholar · View at Scopus
  171. C. Mundhenke, K. Meyer, S. Drew, and A. Friedl, “Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas,” The American Journal of Pathology, vol. 160, no. 1, pp. 185–194, 2002. View at Publisher · View at Google Scholar · View at Scopus
  172. S. W. McLeskey, L. Zhang, B. J. Trock et al., “Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells,” British Journal of Cancer, vol. 73, no. 9, pp. 1053–1062, 1996. View at Publisher · View at Google Scholar · View at Scopus
  173. S. Zaslau, D. R. Riggs, B. J. Jackson et al., “In vitro effects of pentosan polysulfate against malignant breast cells,” The American Journal of Surgery, vol. 188, no. 5, pp. 589–592, 2004. View at Publisher · View at Google Scholar · View at Scopus
  174. J. L. Marshall, A. Wellstein, J. Rae et al., “Phase I trial of orally administered pentosan polysulfate in patients with advanced cancer,” Clinical Cancer Research, vol. 3, no. 12, pp. 2347–2354, 1997. View at Google Scholar · View at Scopus
  175. M. K. Yunmbam and A. Wellstein, “The bacterial polysaccharide tecogalan blocks growth of breast cancer cells in vivo,” Oncology Reports, vol. 8, no. 1, pp. 161–164, 2001. View at Google Scholar · View at Scopus
  176. J. M. Liu, J. Bignon, F. Haroun-Bouhedja et al., “Inhibitory effect of fucoidan on the adhesion of adenocarcinoma cells to fibronectin,” Anticancer Reseach, vol. 25, no. 3 B, pp. 2129–2133, 2005. View at Google Scholar · View at Scopus
  177. M. Di Benedetto, A. Starzec, R. Vassy, G. Y. Perret, M. Crépin, and M. Kraemer, “Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative,” British Journal of Cancer, vol. 88, no. 12, pp. 1987–1994, 2003. View at Publisher · View at Google Scholar · View at Scopus
  178. R. Bagheri-Yarmand, J.-F. Liu, D. Ledoux, J. F. Morere, and M. Crepin, “Erratum: Inhibition of human breast epithelial HBL100 cell proliferation by a dextran derivative (CMDB7): Interference with the FGF2 autocrine loop (Biochemical and Biophysical Research Communications (1997) 239 (424-428)),” Biochemical and Biophysical Research Communications, vol. 241, no. 3, p. 804, 1997. View at Publisher · View at Google Scholar · View at Scopus
  179. J. F. Morere, D. Letourneur, P. Planchon et al., “Inhibitory effect of substituted dextrans on MCF7 human breast cancer cell growth in vitro,” Anti-Cancer Drugs, vol. 3, no. 6, pp. 629–634, 1992. View at Publisher · View at Google Scholar · View at Scopus
  180. P. Bittoun, T. Avramoglou, J. Vassy, M. Crépin, F. Chaubet, and S. Fermandjian, “Low-molecular-weight dextran derivatives (f-CMDB) enter the nucleus and are better cell-growth inhibitors compared with parent CMDB polymers,” Carbohydrate Research, vol. 322, no. 3-4, pp. 247–255, 1999. View at Publisher · View at Google Scholar · View at Scopus
  181. J. Liu, R. Bagheri-Yarmand, Y. Xia, and M. Crépin, “Modulations of breast fibroblast and carcinoma cell interactions by a dextran derivative (CMDB7),” Anticancer Reseach, vol. 17, no. 1 A, pp. 253–258, 1997. View at Google Scholar · View at Scopus
  182. M. D. Benedetto, A. Starzec, B. M. Colombo et al., “Aponecrotic, antiangiogenic and antiproliferative effects of a novel dextran derivative on breast cancer growth in vitro and in vivo,” British Journal of Pharmacology, vol. 135, no. 8, pp. 1859–1871, 2002. View at Publisher · View at Google Scholar · View at Scopus
  183. S. Malherbe, M. Crépin, C. Legrand, and M. X. Wei, “Cytostatic and pro-apoptotic effects of a novel phenylacetate-dextran derivative (NaPaC) on breast cancer cells in interactions with endothelial cells,” Anti-Cancer Drugs, vol. 15, no. 10, pp. 975–981, 2004. View at Publisher · View at Google Scholar · View at Scopus
  184. C. Gervelas, T. Avramoglou, M. Crépin, and J. Jozefonvicz, “Growth inhibition of human melanoma tumor cells by the combination of sodium phenylacetate (NaPA) and substituted dextrans and one NaPA-dextran conjugate,” Anti-Cancer Drugs, vol. 13, no. 1, pp. 37–45, 2002. View at Publisher · View at Google Scholar · View at Scopus
  185. M. Di Benedetto, Y. Kourbali, A. Starzec et al., “Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice,” British Journal of Cancer, vol. 85, no. 6, pp. 917–923, 2001. View at Publisher · View at Google Scholar · View at Scopus
  186. P. Bittoun, R. Bagheri-Yarmand, F. Chaubet, M. Crépin, J. Jozefonvicz, and S. Fermandjian, “Effects of the binding of a dextran derivative on fibroblast growth factor 2: Secondary structure and receptor-binding studies,” Biochemical Pharmacology, vol. 57, no. 12, pp. 1399–1406, 1999. View at Publisher · View at Google Scholar · View at Scopus
  187. M. Di Benedetto, A. Starzec, R. Vassy, G.-Y. Perret, and M. Crépin, “Distinct heparin binding sites on VEGF165 and its receptors revealed by their interaction with a non sulfated glycoaminoglycan (NaPaC),” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1780, no. 4, pp. 723–732, 2008. View at Publisher · View at Google Scholar · View at Scopus
  188. D. Logeart-Avramoglou and J. Jozefonvicz, “Carboxymethyl benzylamide sulfonate dextrans (CMDBS), a family of biospecific polymers endowed with numerous biological properties: A review,” Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 48, no. 4, pp. 578–590, 1999. View at Publisher · View at Google Scholar · View at Scopus
  189. Y. Song, H. Onishi, Y. Machida, and T. Nagai, “Drug release and antitumor characteristics of N-succinyl-chitosan-mitomycin C as an implant,” Journal of Controlled Release, vol. 42, no. 1, pp. 93–100, 1996. View at Publisher · View at Google Scholar · View at Scopus
  190. A. Sabouraud, O. Chappey, T. Dupin, and J. M. Scherrmann, “Binding of colchicine and thiocolchicoside to human serum proteins and blood cells,” International Journal of Clinical Pharmacology and Therapeutics, vol. 32, no. 8, pp. 429–432, 1994. View at Google Scholar · View at Scopus
  191. O. N. Chappey, E. Niel, J. Wautier et al., “Colchicine disposition in human leukocytes after single and multiple oral administration,” Clinical Pharmacology & Therapeutics, vol. 54, no. 4, pp. 360–367, 1993. View at Publisher · View at Google Scholar · View at Scopus
  192. E. Stec-Martyna, M. Ponassi, M. Miele, S. Parodi, L. Felli, and C. Rosano, “Structural comparison of the interaction of tubulin with various ligands affecting microtubule dynamics,” Current Cancer Drug Targets, vol. 12, no. 6, pp. 658–666, 2012. View at Publisher · View at Google Scholar · View at Scopus
  193. J. Seligmann and C. Twelves, “Tubulin: An example of targeted chemotherapy,” Future Medicinal Chemistry, vol. 5, no. 3, pp. 339–352, 2013. View at Publisher · View at Google Scholar · View at Scopus
  194. J. Cortes and M. Vidal, “Beyond taxanes: The next generation of microtubule-targeting agents,” Breast Cancer Research and Treatment, vol. 133, no. 3, pp. 821–830, 2012. View at Publisher · View at Google Scholar · View at Scopus
  195. C. D. Katsetos and P. Dráber, “Tubulins as therapeutic targets in cancer: From bench to bedside,” Current Pharmaceutical Design, vol. 18, no. 19, pp. 2778–2792, 2012. View at Publisher · View at Google Scholar · View at Scopus
  196. H. Ringsdorf, “Structure and properties of pharmacologically active polymers,” Journal of Polymer Science: Polymer Symposia, vol. 51, no. 1, pp. 135–153, 1975. View at Google Scholar · View at Scopus
  197. N. Salahuddin, A. A. Elbarbary, M. L. Salem, and S. Elksass, “Antimicrobial and antitumor activities of 1,2,4-triazoles/polypyrrole chitosan core shell nanoparticles,” Journal of Physical Organic Chemistry, vol. 30, no. 12, p. e3702, 2017. View at Publisher · View at Google Scholar
  198. L. Zhang and T. J. Webster, “Nanotechnology and nanomaterials: promises for improved tissue regeneration,” Nano Today, vol. 4, no. 1, pp. 66–80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  199. J. Y. Wong, R. Langer, and D. E. Ingber, “Electrically conducting polymers can noninvasively control the shape and growth of mammalian cells,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 91, no. 8, pp. 3201–3204, 1994. View at Publisher · View at Google Scholar · View at Scopus
  200. Y. Li, K. G. Neoh, and E. T. Kang, “Controlled release of heparin from polypyrrole-poly(vinyl alcohol) assembly by electrical stimulation,” Journal of Biomedical Materials Research Part A, vol. 73, no. 2, pp. 171–181, 2005. View at Publisher · View at Google Scholar · View at Scopus
  201. M. Shivashankar, B. K. Mandal, and K. Uma, “Chitosan-acryl amide grafted polyethylene glycol interpenetrating polymeric network for controlled release studies of Cefotaxime,” Journal of Chemical and Pharmaceutical Research, vol. 5, no. 5, pp. 140–146, 2013. View at Google Scholar · View at Scopus
  202. M. N. Koopaei, M. R. Khoshayand, S. H. Mostafavi et al., “Docetaxel loaded PEG-PLGA nanoparticles: Optimized drug loading, in-vitro cytotoxicity and in-vivo antitumor effect,” Iranian Journal of Pharmaceutical Research, vol. 13, no. 3, pp. 819–833, 2014. View at Google Scholar · View at Scopus
  203. U. Gaur, S. K. Sahoo, T. K. De, P. C. Ghosh, A. Maitra, and P. K. Ghosh, “Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system,” International Journal of Pharmaceutics, vol. 202, no. 1-2, pp. 1–10, 2000. View at Publisher · View at Google Scholar · View at Scopus
  204. E. Lee, J. Lee, I.-H. Lee et al., “Conjugated chitosan as a novel platform for oral delivery of paclitaxel,” Journal of Medicinal Chemistry, vol. 51, no. 20, pp. 6442–6449, 2008. View at Publisher · View at Google Scholar · View at Scopus
  205. Y. Zhang, M. Huo, J. Zhou, D. Yu, and Y. Wu, “Potential of amphiphilically modified low molecular weight chitosan as a novel carrier for hydrophobic anticancer drug: Synthesis, characterization, micellization and cytotoxicity evaluation,” Carbohydrate Polymers, vol. 77, no. 2, pp. 231–238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  206. M. Khanmohammadi, H. Elmizadeh, and K. Ghasemi, “Investigation of size and morphology of chitosan nanoparticles used in drug delivery system employing chemometric technique,” Iranian Journal of Pharmaceutical Research, vol. 14, no. 3, pp. 665–675, 2015. View at Google Scholar · View at Scopus
  207. M. Agarwal, M. K. Agarwal, N. Shrivastav, S. Pandey, R. Das, and P. Gaur, “Preparation of Chitosan Nanoparticles and their In-vitro Characterization,” International Journal of Life-Sciences Scientific Research, vol. 4, no. 2, pp. 1713–1720, 2018. View at Publisher · View at Google Scholar
  208. P. R. Kamath and D. Sunil, “Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review,” Mini-Reviews in Medicinal Chemistry, vol. 17, no. 15, pp. 1457–1487, 2017. View at Google Scholar
  209. T. Kean and M. Thanou, “Biodegradation, biodistribution and toxicity of chitosan,” Advanced Drug Delivery Reviews, vol. 62, no. 1, pp. 3–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  210. A. Grenha, C. I. Grainger, L. A. Dailey et al., “Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro,” European Journal of Pharmaceutical Sciences, vol. 31, no. 2, pp. 73–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  211. M. Malatesta, S. Grecchi, E. Chiesa, B. Cisterna, M. Costanzo, and C. Zancanaro, “Internalized chitosan nanoparticles persist for long time in cultured cells,” European Journal of Histochemistry, vol. 59, no. 1, Article ID 2492, pp. 61–65, 2015. View at Google Scholar · View at Scopus
  212. U. Aruna, R. Rajalakshmi, Y. Indira Muzib et al., “Role of Chitosan Nanoparticles in Cancer Therapy,” International Journal of Innovative Pharmaceutical Sciences and Research, vol. 4, no. 3, pp. 318–324, 2013. View at Google Scholar
  213. L.-F. Qi, Z.-R. Xu, Y. Li, X. Jiang, and X.-Y. Han, “In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells,” World Journal of Gastroenterology, vol. 11, no. 33, pp. 5136–5141, 2005. View at Google Scholar · View at Scopus
  214. J.-H. Kim, Y.-S. Kim, S. Kim et al., “Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel,” Journal of Controlled Release, vol. 111, no. 1-2, pp. 228–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  215. P. Soni, J. Kaur, and K. Tikoo, “Dual drug-loaded paclitaxel–thymoquinone nanoparticles for effective breast cancer therapy,” Journal of Nanoparticle Research, vol. 17, no. 1, p. 18, 2015. View at Publisher · View at Google Scholar · View at Scopus
  216. H. D. Han, L. S. Mangala, J. W. Lee et al., “Targeted gene silencing using RGD-labeled chitosan nanoparticles,” Clinical Cancer Research, vol. 16, no. 15, pp. 3910–3922, 2010. View at Publisher · View at Google Scholar · View at Scopus
  217. X. Li, M. Min, N. Du et al., “Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine,” Clinical and Developmental Immunology, vol. 2013, Article ID 387023, 8 pages, 2013. View at Publisher · View at Google Scholar
  218. H. Maeda, “The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting,” Advances in Enzyme Regulation, vol. 41, pp. 189–207, 2001. View at Publisher · View at Google Scholar · View at Scopus
  219. P. Yadav, A. Bandyopadhyay, A. Chakraborty, and K. Sarkar, “Enhancement of anticancer activity and drug delivery of chitosan-curcumin nanoparticle via molecular docking and simulation analysis,” Carbohydrate Polymers, vol. 182, pp. 188–198, 2018. View at Publisher · View at Google Scholar · View at Scopus
  220. L. Mary Lazer, B. Sadhasivam, K. Palaniyandi et al., “Chitosan-based nano-formulation enhances the anticancer efficacy of hesperetin,” International Journal of Biological Macromolecules, vol. 107, pp. 1988–1998, 2018. View at Publisher · View at Google Scholar · View at Scopus
  221. J. K. Kim, K.-H. Han, J. T. Lee et al., “Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (milican) for the treatment of small hepatocellular carcinoma,” Clinical Cancer Research, vol. 12, no. 2, pp. 543–548, 2006. View at Publisher · View at Google Scholar · View at Scopus
  222. Medical University of South Carolina, “Study of Chitosan for Pharmacologic Manipulation of AGE (Advanced Glycation End products) Levels in Prostate Cancer Patients,” ClinicalTrials.gov identifier: NCT03712371, 2018, https://clinicaltrials.gov/ct2/show/NCT03668431.
  223. Basel University Hospital, “Comparison of Oral Morphine Versus Nasal Ketamine Spray with Chitosan in Cancer Pain Outpatients,” ClinicalTrials.gov Identifier: NCT02591017, 2018, https://ClinicalTrials.gov/ct2/show/NCT02591017.
  224. S. Won Kim and Samsung Medical Center, “Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan (Medichlore®) After Axillary Dissection for Breast Cancer,” ClinicalTrials.gov Identifier: NCT02967146, 2018, https://ClinicalTrials.gov/ct2/show/NCT02967146.
  225. S. A. C. Eske Corporation, “Randomized Clinical Trial Evaluating the Use of the Laser-assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer,” ClinicalTrials.gov Identifier: NCT03202446, 2018, https://ClinicalTrials.gov/ct2/show/NCT03202446.
  226. I. Segura Duran, “University of Guadalajara, Chitosan Scaffold for Sellar Floor Repair in Endoscopic Endonasal Transsphenoidal Surgery,” ClinicalTrials.gov identifier: NCT03280849, 2018, https://ClinicalTrials.gov/ct2/show/NCT03280849.
  227. K. M. Shields, N. Smock, C. E. McQueen, and P. J. Bryant, “Chitosan for weight loss and cholesterol management,” American Journal of Health-System Pharmacy, vol. 60, no. 13, pp. 1315-1316, 2003. View at Google Scholar
  228. C. Andreadis, K. Vahtsevanos, T. Sidiras, I. Thomaidis, K. Antoniadis, and D. Mouratidou, “5-Fluorouracil and cisplatin in the treatment of advanced oral cancer,” Oral Oncology, vol. 39, no. 4, pp. 380–385, 2003. View at Publisher · View at Google Scholar · View at Scopus
  229. A. Remesh, “Toxicities of anticancer drugs and its management,” International Journal of Basic & Clinical Pharmacology, vol. 1, no. 1, pp. 2–12, 2012. View at Publisher · View at Google Scholar
  230. P. Baldrick, “The safety of chitosan as a pharmaceutical excipient,” Regulatory Toxicology and Pharmacology, vol. 56, no. 3, pp. 290–299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  231. S. Bisht and A. Maitra, “Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol. 1, no. 4, pp. 415–425, 2009. View at Publisher · View at Google Scholar · View at Scopus